Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Journals Home

SIGN IN

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Narrow View

NARROW

Content Type

Meeting Abstract (4)
Journal Articles (2)

Journal

Investigative Ophthalmology & Visual Science (6)

Article Type

ARVO Annual Meeting Abstract (4)
Clinical Trials (1)
Clinical and Epidemiologic Research (1)

Topics

Eye Anatomy and Disorders (2)
Retina (2)
Clinical and Epidemiologic Research (1)
Pharmacology (1)
Spatial Vision (1)
Visual Psychophysics and Physiological Optics (1)

Tags

vision (2)
contrast sensitivity (1)
diabetic macular edema (1)
diabetic retinopathy (1)
eye (1)
health (1)
health-related quality of life (1)
patient preferences (1)
pegaptanib (1)
quality of life (1)

Specify Date Range

From: To: Apply

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract March 2012

What is the value of a mm Hg reduction in intraocular pressure? Results from the Glaucoma Health Policy Model

Andreas M. Pleil; Dennis Lambert; Dustin Stwalley; Joshua D. Stein; David Musch; Paul P. Lee; Sameer Kotak; Colleen Peters; Joel Fain; Steven M. Kymes

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4627. doi:

Clinical Trials September 2011

Changes in Vision- and Health-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Pegaptanib Sodium or Sham

PDF

Jane V. Loftus; Marla B. Sultan; Andreas M. Pleil; for the Macugen 1013 Study Group
TAGS: diabetic macular edema, pegaptanib, vision, sodium, quality of life, health-related quality of life
Invest. Ophthalmol. Vis. Sci.. 2011; 52(10):7498-7505. doi: https://doi.org/10.1167/iovs.11-7613

ARVO Annual Meeting Abstract April 2011

Pegaptanib In Diabetic Macular Edema (DME): Vision-Related Quality of Life (VRQoL) Results at Two Years from a Phase 2/3, 2-year, Randomized (1:1), Sham-Controlled, Double-Masked Trial

Jane V. Loftus; Andreas M. Pleil; Macugen 1013 Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):564. doi:

ARVO Annual Meeting Abstract April 2011

Diabetic Macular Edema (DME) and Treatment of the "Better-Seeing" Eye - An Experimental Bias for Vision-Related Quality of Life (VRQoL) Outcomes?

Andreas M. Pleil; Jack. Mardekian; Jane V. Loftus; Macugen 1013 Study Group

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):577. doi:

ARVO Annual Meeting Abstract April 2011

Development Of A Multi-attribute Instrument For Estimating Of Utilities In People With Glaucoma

Steven M. Kymes; Colleen M. Peters; Kathleen M. Beusterien; Sameer Kotak; Dustin L. Stwalley; Andreas M. Pleil

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5530. doi:

Clinical and Epidemiologic Research July 2010

Patient Preferences for Diabetic Retinopathy Health States

PDF

Shelagh M. Szabo; Kathleen M. Beusterien; Andreas M. Pleil; Barbara Wirostko; Michael J. Potter; Hugh Tildesley; John Gonder; Alexandra Barsdorf; Adrian R. Levy
TAGS: contrast sensitivity, diabetic retinopathy, eye, health, visual acuity, patient preferences, vision
Invest. Ophthalmol. Vis. Sci.. 2010; 51(7):3387-3394. doi: https://doi.org/10.1167/iovs.09-4194

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept